Mechanisms of myocardial reperfusion injury

被引:256
|
作者
Park, JL [1 ]
Lucchesi, BR [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
来源
ANNALS OF THORACIC SURGERY | 1999年 / 68卷 / 05期
关键词
D O I
10.1016/S0003-4975(99)01073-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reperfusion of the ischemic myocardium results in irreversible tissue injury and cell necrosis, leading to decreased cardiac performance. While early reperfusion of the heart is essential in preventing further tissue damage due to ischemia, reintroduction of blood flow can expedite the death of vulnerable, but still viable, myocardial tissue, by initiating a series of events involving both intracellular and extracellular mechanisms. In the last decade, extensive efforts have focused on the role of cytotoxic reactive oxygen species, complement activation, neutrophil adhesion, and the interactions between complement and neutrophils during myocardial reperfusion injury. Without reperfusion, myocardial cell death evolves slowly over the course of hours. In contrast, reperfusion after an ischemic insult of sufficient duration initiates an inflammatory response, beginning with complement activation, followed by the recruitment and accumulation of neutrophils into the reperfused myocardium. Modulation of the inflammatory response, therefore, constitutes a potential pharmacological target to protect the heart from reperfusion injury. Recognition of the initiating factor(s) involved in myocardial reperfusion injury should aid in development of pharmacological interventions to selectively or collectively attenuate the sequence of events that mediate extension of tissue injury beyond that caused by the ischemic insult. (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:1905 / 1912
页数:8
相关论文
共 50 条
  • [41] Dexmedetomidine Alleviating Myocardial Ischemia-Reperfusion Injury in Rats and the Possible Mechanisms
    Wang, Shiqing
    Huang, Qiaowen
    Chen, Xianzhen
    Lin, Chunjin
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (09): : 1703 - 1708
  • [42] Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms
    Marczin, N
    El-Habashi, N
    Hoare, GS
    Bundy, RE
    Yacoub, M
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 420 (02) : 222 - 236
  • [43] Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction
    Cannon, RO
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (02): : 88 - 94
  • [44] Rhynchophylline ameliorates myocardial ischemia/reperfusion injury through the modulation of mitochondrial mechanisms to mediate myocardial apoptosis
    Qin, Qiao-Ji
    Cui, Li-Qiang
    Li, Peng
    Wang, Yong-Bin
    Zhang, Xue-Zhi
    Guo, Ming-Lei
    MOLECULAR MEDICINE REPORTS, 2019, 19 (04) : 2581 - 2590
  • [45] MICROVASCULAR MECHANISMS IN REPERFUSION INJURY
    GAWLOWSKI, DM
    GRANGER, HJ
    FASEB JOURNAL, 1988, 2 (04): : A489 - A489
  • [46] REPERFUSION AND REPERFUSION INJURY IN ACUTE MYOCARDIAL-INFARCTION
    BLACK, L
    COOMBS, VJ
    TOWNSEND, SN
    HEART & LUNG, 1990, 19 (03): : 274 - 286
  • [47] CURRENT RESEARCH VIEWS ON MYOCARDIAL REPERFUSION AND REPERFUSION INJURY
    YELLON, DM
    DOWNEY, JM
    CARDIOSCIENCE, 1990, 1 (02): : 89 - 98
  • [48] MYOCARDIAL REPERFUSION INJURY - ROLE OF MYOCARDIAL HYPOXANTHINE AND XANTHINE IN FREE RADICAL-MEDIATED REPERFUSION INJURY
    ABDELFATTAH, AS
    JESSEN, ME
    LEKVEN, J
    DOHERTY, NE
    BRUNSTING, LA
    WECHSLER, AS
    CIRCULATION, 1988, 78 (05) : 224 - 235
  • [49] The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury
    Zhang, Chen-Hua
    Yan, Yu-Jie
    Luo, Qi
    LIFE SCIENCES, 2024, 340
  • [50] Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury
    Murph, Elizabeth
    Steenbergen, Charles
    CARDIOVASCULAR RESEARCH, 2007, 75 (03) : 478 - 486